USFDA


  • Feb
    27
    By Reuters

    Shares in Jubilant Life Sciences Ltd fell as much as 6. 9 per cent on Wednesday after US health regulators issued a warning letter to the company citing "significant

  • Feb
    22
    By PTI

    Drug firm Lupin today said it has received approval from the US health regulator for its Suprax oral suspension used for treating bacterial infections and expects to commence shipping the

  • Feb
    21
    By PTI

    Drug firm Lupin today said it has received US health regulator's approval to market its generic Lorazepam Oral Concentrate, used for treating anxiety disorders, in the American market.

    Lupin Pharmaceuticals

  • Nov
    30
    By PTI

    Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor until it investigates the issue of potential glass particles in certain lots, the US health regulator

  • Oct
    18
    By PTI

    Drug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablets 'Kurvelo' in the US market.

    The company's subsidiary -- Lupin

  • Oct
    17
    By PTI

    Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.

  • Sep
    28
    By PTI

    Aurobindo Pharma today said it has received approval from the US health regulator to make and market Modafinil tablets used for treating excessive sleepiness disorder in adults the American market.

  • Sep
    20
    By PTI

    Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic Rizatriptan Benzoate tablets used for treating migraine attacks.

    The company's US arm Glenmark